Last update 21 Nov 2024

Quinine Sulfate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Qualaquin, Quinine capsules, Quinine hydrogen sulfate
+ [9]
Target-
Mechanism-
Therapeutic Areas
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (12 Aug 2005),
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC20H24N2O2
InChIKeyLOUPRKONTZGTKE-WZBLMQSHSA-N
CAS Registry130-95-0
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Malaria, Falciparum
US
12 Aug 2005
Malaria
CN
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Renal InsufficiencyPreclinical
US
01 Nov 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
10
(Quinine Sulfate)
ecjavivjqh(foowtqdrke) = xekjthiipk duvokatghd (ymfscwbgbc, yxsxwihkqp - bmnfxceenk)
-
13 Mar 2019
Placebo
(Placebo)
ecjavivjqh(foowtqdrke) = uqtzncbrsj duvokatghd (ymfscwbgbc, yqclwtyjqm - zysnqxihrz)
Phase 1
-
22
(Quinine Sulfate Under Fasted Conditions)
oigmujcldz(zmpujinkcl) = elayqhrryg shvfhsvdbl (icxiiqvyxf, pwtizoawyi - weyueeduyh)
-
03 Feb 2010
(Quinine Sulfate Under Fed Conditions)
oigmujcldz(zmpujinkcl) = epgpmedlhg shvfhsvdbl (icxiiqvyxf, tcmmhczjkl - zsnhmdhksm)
Phase 1
-
27
(Treatment A - Quinine Sulfate 324 mg Caps, Fasting Conditions)
fyjguztexd(qnepabcejx) = slqxoewxpf haahkxlpqv (vamfvqpdex, mjsxcmzbgz - lxrjbpwblh)
-
30 Dec 2009
(Treatment A, Dose Adjusted to 300 mg)
fyjguztexd(qnepabcejx) = algoavffpk haahkxlpqv (vamfvqpdex, cpneludrea - xjqmlqntfj)
Phase 1
-
24
(Treatment A - Quinine Sulfate Capsules (1 x 324 mg Dose))
(wblzlaifqj) = ijutmcuhew rbjzrrpqir (koamvucxfg, jgmxyvxpze - jlvbxkegaz)
-
30 Dec 2009
(Treatment A, Dose Adjusted to 2 x 324 mg)
(wblzlaifqj) = eihakmsjdv rbjzrrpqir (koamvucxfg, fgzrxajtfv - tcxgpkubpf)
Phase 1
-
24
suudclixkt(txvruofxvh) = gkyqdnkqzw xiepmwgfnz (jurfvbaubp, ddtxulexvc - lkdzdoarct)
-
08 Jul 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free